MedPath
FDA Approval

bisoprolol fumarate and hydrochlorothiazide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
August 12, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Bisoprolol(5 mg in 1 1)
Hydrochlorothiazide(6.25 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Denton Pharma, Inc. dba Northwind Pharmaceuticals

Denton Pharma, Inc. dba Northwind Pharmaceuticals

Denton Pharma, Inc. dba Northwind Pharmaceuticals

080355546

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

bisoprolol fumarate and hydrochlorothiazide

Product Details

NDC Product Code
70934-705
Application Number
ANDA079106
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 12, 2021
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
Code: UR59KN573LClass: ACTIBQuantity: 5 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
COPOVIDONEInactive
Code: D9C330MD8BClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL 6000Inactive
Code: 30IQX730WEClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: 0J48LPH2THClass: ACTIBQuantity: 6.25 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath